Stock screener

TNGX

Conviction 16HealthcareScan · Thu, Sep 24, 2026
Hanging man

Tango Therapeutics, Inc. (TNGX) closed at $24.64 (+0.76%) on Sep 24, 2026. Its latest daily candle is a hanging man. Price is below its 50-day and above its 200-day moving average. RSI(14) 52, RS Rating 97, -25.1% from its 52-week high, +175.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

TNGX$24.64+0.76%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 3.31M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Tango Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.tangotx.com ↗
Price24.64
Change+0.76%
Gap+0.10%
Rel volume1.04×
Avg volume2.85M
Avg $ vol67.32M
SMA 2023.46
SMA 5025.37
SMA 20020.50
Price vs 50-2.90%
Price vs 200+20.17%
MA stackmixed
50/200 cross—
Supertrenddown · 26.36
RSI (14)52
MACD hist0.30
MACD cross—
Stoch %K / %D70 / 77
ADX (14)15
+DI / −DI25 / 20
RSI divergenceBullish
MACD divergenceBullish
ATR %6.40%
ADR %6.15%
52w high32.90
52w low6.91
From 52w high-25.12%
Above 52w low+256.51%
New 52w highNo
SqueezeOff
Bollinger width17.39%
%B0.79
Donchian pos57.54%
Donchian high26.85
Donchian low21.63
AVWAP (52w high)27.31
vs AVWAP high-9.81%
AVWAP (52w low)19.24
vs AVWAP low+28.04%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d1.04×
Avg vol (14d)3.31M
Avg vol (20d)2.85M
Avg $ vol (20d)67.32M
Market cap4.15B
RS Rating97 / 99
RS 3m (vs SPY)-22.76%
RS 6m (vs SPY)+1.17%
RS line new highNo
Trend template5/8
Technical rank74.6
1 week+4.87%
1 month-0.55%
3 months-18.26%
6 months+17.98%
1 year+238.39%
YTD+175.87%
P/E-40.89
P/B4.05
P/S66.58
P/FCF-29.68
EPS-0.8700
Div yield—
ROE-9.92%
ROA-9.46%
Debt/Eq—
Current50.82
EV/EBITDA—
Gross margin—
Net margin-162.85%
Rev growth48.29%
EPS growth22.03%
Price target47.71
Target upside93.67%
Analyst ratingBuy
Institutional132.36%
Ent. value3.81B
Revenue0
Net income-55.34M
Gross profit—
Free cash flow-139.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out144.65M
Employees137
ListedWed, Aug 11, 2021
Free float128.95M
Float %89.4%
Short interest42.63M
Days to cover19.7d
Short volume76.4%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.37 vs −$0.31
Last surprise-19.4% miss
Setup gradeD
Conviction16 / 100
Pattern quality—
Tech rank74.6 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TNGX

All disclosures →
No recent disclosed trades by Congress in TNGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TNGX · open-market 2 sells

InsiderSideShares
Crystal Adam
President, R&D · Common Stock · 2026-08-03
Exercise27K
Crystal Adam
President, R&D · Common Stock · 2026-08-03
Sell5.27K
Crystal Adam
President, R&D · Common Stock · 2026-08-03
Sell21.73K
Crystal Adam
President, R&D · Stock Option (Right to Buy) · 2026-08-03
Exercise27K
Lee Sung
Director · Common Stock · 2026-06-05
Grant570
Ketchum John B
Director · Stock Option (Right to Buy) · 2026-06-05
Grant25K
Ketchum John B
Director · Common Stock · 2026-06-05
Grant4K
Rothenberg Mace
Director · Stock Option (Right to Buy) · 2026-06-05
Grant25K
Lee Sung
Director · Stock Option (Right to Buy) · 2026-06-05
Grant3.57K
Calhoun Lesley Ann
Director · Stock Option (Right to Buy) · 2026-06-05
Grant25K

SEC filings

EDGAR filings in TNGX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.